|
US8563573B2
(en)
|
2007-11-02 |
2013-10-22 |
Vertex Pharmaceuticals Incorporated |
Azaindole derivatives as CFTR modulators
|
|
US8193182B2
(en)
|
2008-01-04 |
2012-06-05 |
Intellikine, Inc. |
Substituted isoquinolin-1(2H)-ones, and methods of use thereof
|
|
EP3613743B1
(en)
|
2008-01-04 |
2022-03-16 |
Intellikine, LLC |
Processes for the preparation of 1h-pyrazolo[3,4-d]pyrimidin-4-amine derivatives
|
|
CN104945420A
(zh)
|
2009-06-29 |
2015-09-30 |
因塞特公司 |
作为pi3k抑制剂的嘧啶酮类
|
|
WO2011050211A2
(en)
|
2009-10-21 |
2011-04-28 |
Agios Pharmaceuticals, Inc. |
Methods and compositions for cell-proliferation-related disorders
|
|
EP3561077B1
(en)
|
2009-10-21 |
2022-12-21 |
Les Laboratoires Servier |
Methods for cell-proliferation-related disorders
|
|
WO2011075643A1
(en)
|
2009-12-18 |
2011-06-23 |
Incyte Corporation |
Substituted heteroaryl fused derivatives as pi3k inhibitors
|
|
US8680108B2
(en)
*
|
2009-12-18 |
2014-03-25 |
Incyte Corporation |
Substituted fused aryl and heteroaryl derivatives as PI3K inhibitors
|
|
US9403769B2
(en)
|
2010-02-22 |
2016-08-02 |
Advanced Cancer Therapeutics, Llc |
Small molecule inhibitors of PFKFB3 and glycolytic flux and their methods of use as anti-cancer therapeutics
|
|
US8802868B2
(en)
|
2010-03-25 |
2014-08-12 |
Vertex Pharmaceuticals Incorporated |
Solid forms of (R)-1(2,2-difluorobenzo[D][1,3]dioxo1-5-yl)-N-(1-(2,3-dihydroxypropyl-6-fluoro-2-(1-hydroxy-2-methylpropan2-yl)-1H-Indol-5-yl)-Cyclopropanecarboxamide
|
|
AR081823A1
(es)
|
2010-04-14 |
2012-10-24 |
Incyte Corp |
DERIVADOS FUSIONADOS COMO INHIBIDORES DE PI3Kd
|
|
MX353408B
(es)
|
2010-04-22 |
2018-01-11 |
Vertex Pharma |
Proceso para producir compuestos de cicloalquilcarboxamido-indol.
|
|
US9062055B2
(en)
|
2010-06-21 |
2015-06-23 |
Incyte Corporation |
Fused pyrrole derivatives as PI3K inhibitors
|
|
WO2011161201A1
(en)
|
2010-06-22 |
2011-12-29 |
Kancera Ab |
Bisarylsulfonamides useful as kinase inhibitors in the treatment of inflammation and cancer
|
|
EP2616450B1
(en)
|
2010-09-17 |
2018-05-02 |
Kancera AB |
Sulfonamide compounds
|
|
EP2655374B1
(en)
|
2010-12-20 |
2019-10-23 |
Incyte Holdings Corporation |
N-(1-(substituted-phenyl)ethyl)-9h-purin-6-amines as pi3k inhibitors
|
|
TWI674262B
(zh)
|
2011-01-10 |
2019-10-11 |
美商英菲尼提製藥股份有限公司 |
製備異喹啉酮之方法及異喹啉酮之固體形式
|
|
GB201103762D0
(en)
|
2011-03-07 |
2011-04-20 |
Vib Vzw |
Means and methods for the treatment of neurodegenerative disorders
|
|
US9108984B2
(en)
|
2011-03-14 |
2015-08-18 |
Incyte Corporation |
Substituted diamino-pyrimidine and diamino-pyridine derivatives as PI3K inhibitors
|
|
WO2012135009A1
(en)
|
2011-03-25 |
2012-10-04 |
Incyte Corporation |
Pyrimidine-4,6-diamine derivatives as pi3k inhibitors
|
|
US9492418B2
(en)
|
2011-05-10 |
2016-11-15 |
Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College |
Inhibitors of PFKFB3 for cancer therapy
|
|
RU2477723C2
(ru)
|
2011-06-16 |
2013-03-20 |
Общество С Ограниченной Ответственностью "Фьюжн Фарма" |
Ингибиторы протеинкиназ (варианты), их применение для лечения онкологических заболеваний и фармацевтическая композиция на их основе
|
|
GB201112145D0
(en)
|
2011-07-15 |
2011-08-31 |
Vib Vzw |
Means and methods for the treatment of pathological angiogenesis
|
|
KR102507287B1
(ko)
|
2011-09-02 |
2023-03-07 |
인사이트 홀딩스 코포레이션 |
Ｐｉ３ｋ 억제제로서 헤테로시클릴아민
|
|
US10000449B2
(en)
|
2011-12-22 |
2018-06-19 |
Kancera Ab |
Bisarylsulfonamides useful in the treatment of inflammation and cancer
|
|
CA2859586C
(en)
|
2011-12-22 |
2020-03-31 |
Kancera Ab |
Bisarylsulfonamides useful in the treatment of inflammation and cancer
|
|
IN2014DN08886A
(https=)
*
|
2012-03-29 |
2015-05-22 |
Advanced Cancer Therapeutics Llc |
|
|
AR090548A1
(es)
|
2012-04-02 |
2014-11-19 |
Incyte Corp |
Azaheterociclobencilaminas biciclicas como inhibidores de pi3k
|
|
US8828998B2
(en)
|
2012-06-25 |
2014-09-09 |
Infinity Pharmaceuticals, Inc. |
Treatment of lupus, fibrotic conditions, and inflammatory myopathies and other disorders using PI3 kinase inhibitors
|
|
EP2914296B2
(en)
|
2012-11-01 |
2021-09-29 |
Infinity Pharmaceuticals, Inc. |
Treatment of cancers using pi3 kinase isoform modulators
|
|
CN105164124B
(zh)
|
2012-11-19 |
2017-03-15 |
诺华股份有限公司 |
用于治疗寄生虫疾病的化合物和组合物
|
|
US8871754B2
(en)
|
2012-11-19 |
2014-10-28 |
Irm Llc |
Compounds and compositions for the treatment of parasitic diseases
|
|
JP6223563B2
(ja)
|
2013-10-14 |
2017-11-01 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
選択的に置換されたキノリン化合物
|
|
CN105636945B
(zh)
|
2013-10-14 |
2017-11-17 |
卫材R&D管理有限公司 |
选择性取代的喹啉化合物
|
|
RU2744460C2
(ru)
|
2014-04-15 |
2021-03-09 |
Вертекс Фармасьютикалз Инкорпорейтед |
Фармацевтические композиции для лечения заболеваний, опосредованных муковисцидозным трансмембранным регулятором проводимости
|
|
WO2015160975A2
(en)
|
2014-04-16 |
2015-10-22 |
Infinity Pharmaceuticals, Inc. |
Combination therapies
|
|
GB201407693D0
(en)
*
|
2014-05-01 |
2014-06-18 |
Univ Montfort |
Compound
|
|
WO2015191677A1
(en)
|
2014-06-11 |
2015-12-17 |
Incyte Corporation |
Bicyclic heteroarylaminoalkyl phenyl derivatives as pi3k inhibitors
|
|
SI3831833T1
(sl)
|
2015-02-27 |
2023-03-31 |
Incyte Holdings Corporation |
Postopki za pripravo inhibitorja PI3K
|
|
US10881654B2
(en)
*
|
2015-04-24 |
2021-01-05 |
University Of Louisville Research Foundation, Inc. |
Selective PFKFB4 inhibitors for the treatment of cancer
|
|
US9732097B2
(en)
|
2015-05-11 |
2017-08-15 |
Incyte Corporation |
Process for the synthesis of a phosphoinositide 3-kinase inhibitor
|
|
US9988401B2
(en)
|
2015-05-11 |
2018-06-05 |
Incyte Corporation |
Crystalline forms of a PI3K inhibitor
|
|
WO2016180537A1
(en)
*
|
2015-05-13 |
2016-11-17 |
Selvita S.A. |
Substituted quinoxaline derivatives
|
|
US20180147198A1
(en)
*
|
2015-05-28 |
2018-05-31 |
University Of Louisville Research Foundation, Inc. |
Combinations of pfkfb3 inhibitors and immune checkpoint inhibitors to treat cancer
|
|
WO2017208174A2
(en)
*
|
2016-05-31 |
2017-12-07 |
The Regents Of The University Of California |
Methods of treating disease with pfkfb3 inhibitors
|
|
RU2754507C2
(ru)
|
2016-06-24 |
2021-09-02 |
Инфинити Фармасьютикалз, Инк. |
Комбинированная терапия
|
|
SG11202000230VA
(en)
|
2017-07-11 |
2020-02-27 |
Vertex Pharma |
Carboxamides as modulators of sodium channels
|
|
US10774046B2
(en)
|
2017-10-26 |
2020-09-15 |
University Of Louisville Research Foundation, Inc. |
Inhibitors for the treatment of cancer and related methods
|
|
CA3101323A1
(en)
|
2018-06-01 |
2019-12-05 |
Incyte Corporation |
Dosing regimen for the treatment of pi3k related disorders
|
|
WO2020030613A1
(en)
|
2018-08-07 |
2020-02-13 |
Kemijski Institut |
Small molecule-inhibitors of 6-phosphofructo-1-kinase for reducing lactate generation by cancer cells
|
|
CN109535068B
(zh)
*
|
2018-12-26 |
2022-07-29 |
中国药科大学 |
吡啶取代查尔酮类化合物或其可药用的盐及其制备方法和用途
|
|
WO2020146612A1
(en)
|
2019-01-10 |
2020-07-16 |
Vertex Pharmaceuticals Incorporated |
Esters and carbamates as modulators of sodium channels
|
|
US12441703B2
(en)
|
2019-01-10 |
2025-10-14 |
Vertex Pharmaceuticals Incorporated |
Carboxamides as modulators of sodium channels
|
|
CA3164134A1
(en)
|
2019-12-06 |
2021-06-10 |
Vertex Pharmaceuticals Incorporated |
Substituted tetrahydrofurans as modulators of sodium channels
|
|
SI4347031T1
(sl)
|
2021-06-04 |
2026-01-30 |
Vertex Pharmaceuticals Incorporated |
N-(hidroksialkil (hetero)aril) tetrahidrofuran karboksamidi kot modulatorji natrijevih kanalčkov
|
|
LU102863B1
(en)
|
2021-10-19 |
2023-04-20 |
Kemijski Inst |
Small molecule-inhibitors of 6-phosphofructo-1-kinase for reducing Reactive oxygen species (ROS) generation by cancer cells
|